Ha habido 50 transacciones internas recientes registradas para Ardelyx, Inc. (ARDX), incluyendo 18 compras y 27 ventas. El total de compras internas fue valorado en $17.5M y el total de ventas internas en $1.3M.
Internos destacados con actividad reciente incluyen Dinavahi Rajani, Raab Michael, Mott David M. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — ARDX
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-04-01 |
Dinavahi Rajani |
Chief Medical Officer |
Desconocido |
301,000 |
$6.11 |
$1.84M |
- |
| 2026-03-16 |
Raab Michael |
President & CEO |
Ejercicio de Opciones (Venta) |
20,833 |
$0.99 |
$20.62K |
374,168 |
| 2026-02-24 |
Raab Michael |
President & CEO |
Ejercicio de Opciones (Venta) |
20,833 |
$0.99 |
$20.62K |
395,001 |
| 2026-02-20 |
Mott David M |
Director |
Compra Informativa |
333,333 |
$5.84 |
$1.95M |
3,302,918 |
| 2026-02-20 |
Bishop John E |
See Remarks |
Venta Informativa |
1 |
$5.70 |
$5.70 |
339,151 |
| 2026-02-20 |
Raab Michael |
President & CEO |
Venta Informativa |
2 |
$5.70 |
$11.40 |
1,856,986 |
| 2026-02-20 |
Williams Laura A |
See Remarks |
Venta Informativa |
984 |
$5.71 |
$5.62K |
436,082 |
| 2026-02-20 |
Kelliher Mike |
See Remarks |
Venta Informativa |
2 |
$5.71 |
$11.41 |
364,666 |
| 2026-02-20 |
Foster Eric Duane |
Chief Commercial Officer |
Venta Informativa |
1 |
$5.70 |
$5.70 |
425,970 |
| 2026-02-20 |
Reilly Joseph James |
See Remarks |
Venta Informativa |
2 |
$5.70 |
$11.40 |
151,790 |
| 2026-02-20 |
Brady James Parker |
Chief Human Resources Officer |
Venta Informativa |
309 |
$5.71 |
$1.77K |
262,912 |
| 2026-02-20 |
Hohenleitner Susan |
Chief Financial Officer |
Venta Informativa |
247 |
$5.71 |
$1.41K |
230,533 |
| 2026-01-23 |
Bishop John E |
See Remarks |
Concesión de RSU |
186,500 |
$7.77 |
$1.45M |
186,500 |
| 2026-01-23 |
Raab Michael |
President & CEO |
Concesión de RSU |
669,330 |
$7.77 |
$5.2M |
669,330 |
| 2026-01-23 |
Williams Laura A |
Chief Patient Officer |
Concesión de RSU |
124,040 |
$7.77 |
$963.79K |
124,040 |
| 2026-01-23 |
Kelliher Mike |
See Remarks |
Concesión de RSU |
154,625 |
$7.77 |
$1.2M |
154,625 |
| 2026-01-23 |
Foster Eric Duane |
Chief Commercial Officer |
Concesión de RSU |
206,915 |
$7.77 |
$1.61M |
206,915 |
| 2026-01-23 |
Brady James Parker |
Chief Human Resources Officer |
Concesión de RSU |
149,185 |
$7.77 |
$1.16M |
149,185 |
| 2026-01-23 |
Hohenleitner Susan |
Chief Financial Officer |
Concesión de RSU |
128,505 |
$7.77 |
$998.48K |
128,505 |
| 2026-01-23 |
Reilly Joseph James |
See Remarks |
Concesión de RSU |
69,360 |
$7.77 |
$538.93K |
69,360 |
| 2026-01-08 |
Williams Laura A |
Chief Patient Officer |
Ejercicio de Opciones (Venta) |
- |
$0.99 |
- |
62,000 |
| 2025-11-21 |
Grammer Elizabeth A |
See Remarks |
Venta Informativa |
5,995 |
$5.54 |
$33.19K |
299,895 |
| 2025-11-21 |
Raab Michael |
President & CEO |
Venta Informativa |
46,887 |
$5.54 |
$259.61K |
1,455,363 |
| 2025-11-21 |
Williams Laura A |
Chief Patient Officer |
Venta Informativa |
6,426 |
$5.54 |
$35.58K |
359,896 |
| 2025-11-21 |
Kelliher Mike |
See Remarks |
Venta Informativa |
5,560 |
$5.54 |
$30.79K |
271,181 |
| 2025-11-21 |
Foster Eric Duane |
Chief Commercial Officer |
Venta Informativa |
5,814 |
$5.54 |
$32.19K |
295,684 |
| 2025-11-21 |
Reilly Joseph James |
See Remarks |
Venta Informativa |
11,086 |
$5.54 |
$61.38K |
108,914 |
| 2025-11-04 |
Hohenleitner Susan |
Chief Financial Officer |
Desconocido |
578,104 |
$5.01 |
$2.9M |
- |
| 2025-08-26 |
Williams Laura A |
Chief Patient Officer |
Ejercicio de Opciones (Venta) |
50,000 |
$0.99 |
$49.5K |
112,000 |
| 2025-08-21 |
Grammer Elizabeth A |
See Remarks |
Venta Informativa |
5,841 |
$5.93 |
$34.65K |
305,890 |
| 2025-08-21 |
Raab Michael |
President & CEO |
Venta Informativa |
45,687 |
$5.93 |
$271K |
1,502,250 |
| 2025-08-21 |
Renz Justin A |
Chief Financial Officer |
Venta Informativa |
7,037 |
$5.93 |
$41.74K |
409,052 |
| 2025-08-21 |
Williams Laura A |
Chief Patient Officer |
Venta Informativa |
6,261 |
$5.93 |
$37.14K |
396,322 |
| 2025-08-21 |
Foster Eric Duane |
Chief Commercial Officer |
Venta Informativa |
15,308 |
$5.93 |
$90.8K |
301,498 |
| 2025-08-21 |
Kelliher Mike |
Chief Business Officer |
Venta Informativa |
5,417 |
$5.93 |
$32.13K |
276,741 |
| 2025-08-01 |
Bishop John E |
See Remarks |
Desconocido |
327,000 |
$4.49 |
$1.47M |
- |
| 2025-08-01 |
Conner Edward R. |
Chief Medical Officer |
Desconocido |
463,268 |
$5.21 |
$2.41M |
- |
| 2025-06-18 |
Brady James Parker |
Chief Human Resources Officer |
Desconocido |
250,000 |
$3.93 |
$982.5K |
- |
| 2025-06-18 |
Mott David M |
Director |
Concesión de RSU |
54,059 |
$3.61 |
$195.15K |
54,059 |
| 2025-06-18 |
Bertrand William C Jr |
Director |
Concesión de RSU |
54,059 |
$3.61 |
$195.15K |
54,059 |
| 2025-06-18 |
Rodgers Richard J |
Director |
Concesión de RSU |
54,059 |
$3.61 |
$195.15K |
54,059 |
| 2025-06-18 |
Bazemore Robert B |
Director |
Concesión de RSU |
41,551 |
- |
- |
41,551 |
| 2025-06-18 |
Parsey Merdad |
Director |
Concesión de RSU |
15,235 |
- |
- |
57,291 |
| 2025-06-18 |
Cadoret-manier Onaiza |
Director |
Concesión de RSU |
54,059 |
$3.61 |
$195.15K |
54,059 |
| 2025-06-18 |
Bhanji Muna |
Director |
Concesión de RSU |
54,059 |
$3.61 |
$195.15K |
54,059 |
| 2025-06-16 |
Mott David M |
Director |
Compra Informativa |
200,000 |
$3.63 |
$725.88K |
2,896,871 |
| 2025-06-09 |
Mott David M |
Director |
Compra Informativa |
200,000 |
$3.69 |
$737.26K |
2,696,871 |
| 2025-05-20 |
Grammer Elizabeth A |
See Remarks |
Venta Informativa |
5,992 |
$4.08 |
$24.46K |
311,731 |
| 2025-05-20 |
Raab Michael |
President & CEO |
Venta Informativa |
46,817 |
$4.08 |
$191.08K |
1,547,937 |
| 2025-05-20 |
Renz Justin A |
Chief Financial Officer |
Venta Informativa |
7,218 |
$4.08 |
$29.46K |
416,089 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
